Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine

BMC Medicine

Armando Arredondo¹ 

[1] National Institute of Public Health-Mexico, Visiting Professor in sabbatical period, School of Public Health of the University of Montreal, 7101 avenue du Parc, 3e étage, Bureau 3074-5, Montreal H3N 1X9, Qébec, Canada

关键词: Latin American countries;    Economic burden;    Epidemiological transition;    Universal coverage;    Chronic diseases;    Diabetes;   

Others  :  1121536
DOI  :  10.1186/s12916-014-0136-z

 received in 2014-05-06, accepted in 2014-07-23,  发布年份 2014

【 摘 要 】

Background

Despite advances in medicine, health systems in Latin America are not coping with the challenges of chronic diseases. Incidence of disease and the economic burdens as a consequence have both increased in recent years. We have chosen Type 2 diabetes as an example to highlight the challenges posed by chronic diseases, in terms of the epidemiological transition and the economic burden of the demand for services to treat such problems.

Discussion

Current health systems are not prepared to respond in a comprehensive manner to all phases of the natural history of the disease. There are new models of universal coverage, but resources and models of care are focused on programs aimed at healing/rehabilitation, and very sparsely at detection/prevention.

Summary

In this scenario, chronic problems have alarmingly increased direct costs (medical care) and indirect costs (temporary disability, permanent disability and premature mortality). If more resources are not assigned to preventive medicine, these trends, in addition to not meeting the needs of the population, will financially collapse health systems and the patients’ pockets. This Opinion piece outlines some possible changes that can be implemented to better prepare the health services in Latin American countries.

【 授权许可】

   
2014 Arredondo; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Shaw J, Sicree R, Zimment P: Global estimates of the prevalence of diabetes for 2110 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
• [2]Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet 2012, 380:2095-2117.
• [3]Frenk J, Bobadilla JL, Stern C, Lozano R: The epidemiological transition in Latin America. Bol Oficina Sanit Panam 1991, 111:485-496.
• [4]Arredondo A, Zúñiga A: Economic consequences of epidemiological changes in diabetes in middle income countries: the Mexican case. Diabetes Care 2004, 27:104-109.
• [5]International Diabetes Federation: Direct Cost to the Health Care Sector. Diabetes Health Economics. Brussels, Belgium; 2010.
• [6]Amos AF, McCarty D, Zimmet P: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 2010, 5:S51-S85.
• [7]Arredondo A, Icaza E: Financial requirements for diabetes in Latin America: evidence and implications for the health system and for patients in Mexico. Diabetologia 2009, 52:1693-1695.
• [8]Barcelo A, Aedo C, Rajpathak S, Robles S: The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 2003, 81:19-27.
• [9]Zhang P, Zhang X, Brown J, Vistisen D, Sicree R: Global healthcare expenditure on diabetes for 2010 and 2030. Diabet Res 2010, 87:293-301.
• [10]Bank W: Universal Healthcare on the Rise in Latin America. Working Paper. Washington D.C; 2013.
• [11]Giedion U: Designing and implementing explicit health benefits packages in Latin America. In Report of the Roundtable Discussion on Universal Health Coverage. Policy Wisdom, Washington D.C; 2013:6-7.
• [12]Cortez R, Romero D: Increasing Utilization of Health Care Services among the Uninsured Population: the Plan Nacer Program. Working Paper No. 74956. World Bank Series, Buenos Aires; 2013.
• [13]Quentin T: Poverty and Policy in Latin America and the Caribbean, Technical Paper. World Bank, Washington DC; 2013.
• [14]Cercone J: Asociación público-privada para la atención a la salud. In El desafío de la reforma en salud. Foro de Europa y América sobre las Reformas del Sector Salud. Nota Técnica. Banco Mundial, Santiago de Chile; 2014.
• [15]Arredondo A, Reyes G: Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PloS One 2013, 8:e68443.
• [16]Avezum A, Braga J, Santos I, Marín J, Piegas L: Cardiovascular disease in South America: current status and opportunities for prevention. Heart 2009, 95:1475-1482.
• [17]Arredondo A, Orozco E, Aviles R: Evidence on equity, governance and financing after health care reform in Mexico: lessons for Latin American countries.Jou Saúde e Sociedade, in press.
• [18]Nava G: Adherencia al Tratamiento y Deserción de Pacientes con Diabetes, Informe Técnico Parcial. Universidad Autonoma de Hidalgo, México; 2012.